| Product Code: ETC12702766 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Nuclear Medicines Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Nuclear Medicines Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Nuclear Medicines Market - Industry Life Cycle |
3.4 Taiwan Nuclear Medicines Market - Porter's Five Forces |
3.5 Taiwan Nuclear Medicines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Taiwan Nuclear Medicines Market Revenues & Volume Share, By Application Area, 2021 & 2031F |
3.7 Taiwan Nuclear Medicines Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Taiwan Nuclear Medicines Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
4 Taiwan Nuclear Medicines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Taiwan, leading to higher demand for nuclear medicines for diagnosis and treatment. |
4.2.2 Technological advancements in nuclear medicine imaging techniques, driving the adoption of nuclear medicines in Taiwan. |
4.2.3 Growing investments in healthcare infrastructure and facilities, supporting the development and uptake of nuclear medicines in Taiwan. |
4.3 Market Restraints |
4.3.1 Stringent regulations and safety concerns surrounding the use of nuclear medicines, leading to limited market expansion. |
4.3.2 High upfront costs associated with setting up nuclear medicine facilities and equipment, hindering market growth. |
4.3.3 Limited awareness and education among healthcare professionals and patients about the benefits of nuclear medicines, impacting adoption rates in Taiwan. |
5 Taiwan Nuclear Medicines Market Trends |
6 Taiwan Nuclear Medicines Market, By Types |
6.1 Taiwan Nuclear Medicines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Nuclear Medicines Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Taiwan Nuclear Medicines Market Revenues & Volume, By Diagnostic Radiopharmaceuticals, 2021 - 2031F |
6.1.4 Taiwan Nuclear Medicines Market Revenues & Volume, By Therapeutic Radiopharmaceuticals, 2021 - 2031F |
6.2 Taiwan Nuclear Medicines Market, By Application Area |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Nuclear Medicines Market Revenues & Volume, By Oncology Imaging, 2021 - 2031F |
6.2.3 Taiwan Nuclear Medicines Market Revenues & Volume, By Thyroid Treatment, 2021 - 2031F |
6.2.4 Taiwan Nuclear Medicines Market Revenues & Volume, By Cardiac Imaging, 2021 - 2031F |
6.2.5 Taiwan Nuclear Medicines Market Revenues & Volume, By Bone Pain Palliation, 2021 - 2031F |
6.3 Taiwan Nuclear Medicines Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Taiwan Nuclear Medicines Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Taiwan Nuclear Medicines Market Revenues & Volume, By Endocrinology Clinics, 2021 - 2031F |
6.3.4 Taiwan Nuclear Medicines Market Revenues & Volume, By Cardiology Centers, 2021 - 2031F |
6.3.5 Taiwan Nuclear Medicines Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.4 Taiwan Nuclear Medicines Market, By Product Type |
6.4.1 Overview and Analysis |
6.4.2 Taiwan Nuclear Medicines Market Revenues & Volume, By Technetium-99m, 2021 - 2031F |
6.4.3 Taiwan Nuclear Medicines Market Revenues & Volume, By Iodine-131, 2021 - 2031F |
6.4.4 Taiwan Nuclear Medicines Market Revenues & Volume, By Thallium-201, 2021 - 2031F |
6.4.5 Taiwan Nuclear Medicines Market Revenues & Volume, By Samarium-153, 2021 - 2031F |
7 Taiwan Nuclear Medicines Market Import-Export Trade Statistics |
7.1 Taiwan Nuclear Medicines Market Export to Major Countries |
7.2 Taiwan Nuclear Medicines Market Imports from Major Countries |
8 Taiwan Nuclear Medicines Market Key Performance Indicators |
8.1 Average waiting time for nuclear medicine procedures in Taiwan. |
8.2 Number of research studies and clinical trials involving nuclear medicines conducted in Taiwan. |
8.3 Percentage of healthcare facilities in Taiwan offering nuclear medicine services. |
8.4 Patient satisfaction scores related to nuclear medicine services in Taiwan. |
8.5 Adoption rate of new nuclear medicine technologies and techniques in Taiwan. |
9 Taiwan Nuclear Medicines Market - Opportunity Assessment |
9.1 Taiwan Nuclear Medicines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Taiwan Nuclear Medicines Market Opportunity Assessment, By Application Area, 2021 & 2031F |
9.3 Taiwan Nuclear Medicines Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Taiwan Nuclear Medicines Market Opportunity Assessment, By Product Type, 2021 & 2031F |
10 Taiwan Nuclear Medicines Market - Competitive Landscape |
10.1 Taiwan Nuclear Medicines Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Nuclear Medicines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here